View
Semantic Search: 😱 GLP-3 (RETA) vs MOTS-C 😱
😱 GLP-3 (RETA) vs MOTS-C 😱
Score 0.836
· Account tjphuhs@gmail.com
· 2/11/2026, 10:30:15 AM
😱 GLP-3 (RETA) vs MOTS-C 😱 from info@somachems.com on 2026-02-11T15:30:15.000Z Take your metabolic research to the next level This email was sent to you as HTML-only. To view it, please visit: https://qfq.soundestlink.com/ce/v/68a3ebb905e51bffe64c8eaf/698c2a47dd9732c63e198315 ************************** Make sure you keep getting our latest offers and add info@somachems.com to your address book. Unsubscribe https://qfq.soundestlink.com/contactsPreferences/v2/unsubscribe/?b=686794eb7d5d9b4678a0b
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.645
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z to Research Radar. For the full experience, upgrade your subscription. > Upgrade to paid > > Share > > > Like > Comment > Restack > > © 2026 Derek Pruski > 548 Market Street PMB 72296, San Francisco, CA 94104 > Unsubscribe
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.645
· Account tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z to Research Radar. For the full experience, upgrade your subscription. > Upgrade to paid > > Share > > > Like > Comment > Restack > > © 2026 Derek Pruski > 548 Market Street PMB 72296, San Francisco, CA 94104 > Unsubscribe
The Next Wave of GLP-1s Is Coming
Score 0.623
· Account tjphuhs@gmail.com
· 3/31/2026, 6:05:53 PM
The Next Wave of GLP-1s Is Coming from huntershealthhacks@mail.beehiiv.com on 2026-03-31T22:05:53.000Z fat and energy expenditure benefits that GIP agonism simply does not. Retatrutide is still king on paper. It hits all three receptors and delivers the most weight loss. But survodutide and mazdutide are not far behind. And for people who need an alternative, or who want to cycle compounds to maintain receptor sensitivity, these fill a real gap. ——————————————————————————— **They're Not the Same
New post in the group My Community (Members Only).
Score 0.612
· Account tjphuhs@gmail.com
· 2/22/2026, 10:11:25 PM
New post in the group My Community (Members Only). from info@totalwellconnect.com on 2026-02-23T03:11:25.000Z NEW POST Hi there, bruno_tanya posted something in the group My Community (Members Only) . Stop by and leave a comment. Post: I am at paramount peptides and there is no Reta? Actually there is no Glp period what’s up? Click on the link below to open the message in a browser: https://thepeptidecommunity.com/so/tr/86d55f27-4ce2-40d2-8f3b-ac489f2ae1a4 You've received this email because you
GLP-1 vs GLP-2 vs GLP-3
Score 0.611
· Account tjphuhs@gmail.com
· 5/14/2026, 9:00:21 AM
GLP-1 vs GLP-2 vs GLP-3 from happy@happypeptides.com on 2026-05-14T13:00:21.000Z A simple comparison of the three. This email was sent to you as HTML-only. To view it, please visit: https://wfg.soundestlink.com/ce/v/68a8a1cb95c4ac11474be077/6a04d2931ac007f30c9a1cd2 ************************** Make sure you keep getting our latest offers and add happy@happypeptides.com to your address book. Unsubscribe https://wfg.soundestlink.com/contactsPreferences/v2/unsubscribe/?b=68a8a136cfa3b70cffc67e5f&c=68
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.609
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z ---------- Forwarded message ---------- From: Derek from Research Radar <derekpruski@substack.com> Date: Apr 24, 2026 at 1:18 PM -0400 To: tjphuhs@gmail.com Subject: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds > I get a lot of questions about MOTS-c versus NAD+, and one of the most common is which one res
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.609
· Account tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z ---------- Forwarded message ---------- From: Derek from Research Radar <derekpruski@substack.com> Date: Apr 24, 2026 at 1:18 PM -0400 To: tjphuhs@gmail.com Subject: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds > I get a lot of questions about MOTS-c versus NAD+, and one of the most common is which one res
The Next Wave of GLP-1s Is Coming
Score 0.605
· Account tjphuhs@gmail.com
· 3/31/2026, 6:05:53 PM
The Next Wave of GLP-1s Is Coming from huntershealthhacks@mail.beehiiv.com on 2026-03-31T22:05:53.000Z the GLP-1 world. They're not retatrutide. But they're not far off. And they fill important gaps that tirzepatide and semaglutide can't address. Whether you use them as a primary GLP-1, an alternative for people who don't tolerate retatrutide well, or a rotation compound to maintain receptor sensitivity, I think they're worth researching. Remember to check out the video for the full breakdown. A
Retatrutide Is Too Good… And That’s The Problem
Score 0.602
· Account tjphuhs@gmail.com
· 3/24/2026, 9:24:24 PM
Retatrutide Is Too Good… And That’s The Problem from onthepen@substack.com on 2026-03-25T01:24:24.000Z View this post on the web at https://onthepen.substack.com/p/retatrutide-is-too-good-and-thats There’s a lot shifting right now in the world of GLP-1s, and if you rely on compounded or research-grade options, this week’s updates may feel especially important. From new signals out of Washington that could impact access, to powerful new data on next-generation treatments like retatrutide, to wher
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.594
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z at the signaling layer, NAD+ at the substrate layer. The “anti-aging” framing in marketing is usually oversimplified. The research is more nuanced and mostly preclinical. > Can they be studied together? > Mechanistically they don’t conflict, and there’s some theoretical rationale for why they might be complementary (signal plus substrate). But from a
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.594
· Account tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z at the signaling layer, NAD+ at the substrate layer. The “anti-aging” framing in marketing is usually oversimplified. The research is more nuanced and mostly preclinical. > Can they be studied together? > Mechanistically they don’t conflict, and there’s some theoretical rationale for why they might be complementary (signal plus substrate). But from a
The Next Wave of GLP-1s Is Coming
Score 0.592
· Account tjphuhs@gmail.com
· 3/31/2026, 6:05:53 PM
The Next Wave of GLP-1s Is Coming from huntershealthhacks@mail.beehiiv.com on 2026-03-31T22:05:53.000Z approved doses in China are 4 mg and 6 mg per week. The titration protocol starts at 2 mg, then moves to 4 mg, then to 6 mg, with about four weeks between each step. The 9 mg dose is the highest studied in China's GLORY-2 trial. The US is evaluating doses up to 16 mg. Survodutide is also once weekly. Phase 3 target doses are 3.6 mg and 6.0 mg. Phase 2 used aggressive bi-weekly escalation and it
Reta vs. Cancer
Score 0.591
· Account tjphuhs@gmail.com
· 2/24/2026, 6:06:31 PM
Reta vs. Cancer from huntershealthhacks@mail.beehiiv.com on 2026-02-24T23:06:31.000Z stress without excessive suppression of appetite or energy, that becomes a sustainable strategy. Consistency matters more than intensity. Subtle improvements maintained over the years can compound in powerful ways. ——————————————————————————— **Reta Beyond Fat Loss** For years, I have emphasized that GLP-1 agents are metabolic regulators rather than simple fat loss drugs. Retatrutide extends that concept because
Fwd: Stuck on Reta?
Score 0.588
· Account tjphuhs@gmail.com
· 5/9/2026, 1:49:02 PM
Fwd: Stuck on Reta? from tjphuhs@gmail.com on 2026-05-09T17:49:02.000Z why I personally only use MT1, why MT2 is more like a tanning bed (use it for an event, not year-round), and how I think about the cancer question for each one. There's also a tangent about tanning beds in the early 2000s that probably explains a lot about a generation of skin issues. > > Perimenopausal Sleep Problems > This is one of the biggest topics we get asked about. One listener was on MK-677, sleeping great, but binge
Fwd: Stuck on Reta?
Score 0.588
· Account oc.tjphuhs@gmail.com
· 5/9/2026, 1:49:02 PM
Fwd: Stuck on Reta? from tjphuhs@gmail.com on 2026-05-09T17:49:02.000Z why I personally only use MT1, why MT2 is more like a tanning bed (use it for an event, not year-round), and how I think about the cancer question for each one. There's also a tangent about tanning beds in the early 2000s that probably explains a lot about a generation of skin issues. > > Perimenopausal Sleep Problems > This is one of the biggest topics we get asked about. One listener was on MK-677, sleeping great, but binge
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.587
· Account tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z > Here’s a walkthrough to help you think about which direction matches your research interests. Read through top to bottom, stop at the first question where the answer is yes. > 1. Is your focus primarily metabolic pathways? (glucose handling, insulin sensitivity, AMPK signaling) > → MOTS-c is more targeted. Focus area: AMPK activation literature. Key
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.587
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z > Here’s a walkthrough to help you think about which direction matches your research interests. Read through top to bottom, stop at the first question where the answer is yes. > 1. Is your focus primarily metabolic pathways? (glucose handling, insulin sensitivity, AMPK signaling) > → MOTS-c is more targeted. Focus area: AMPK activation literature. Key
Fwd: MOTS-c & Morning Workout Timing — A Beginner-Friendly Breakdown
Score 0.586
· Account tjphuhs@gmail.com
· 3/21/2026, 1:06:18 PM
Fwd: MOTS-c & Morning Workout Timing — A Beginner-Friendly Breakdown from tjphuhs@gmail.com on 2026-03-21T17:06:18.000Z ---------- Forwarded message ---------- From: Derek from Peptide Price <derekpruski@substack.com> Date: Mar 21, 2026 at 8:24 AM -0400 To: tjphuhs@gmail.com Subject: MOTS-c & Morning Workout Timing — A Beginner-Friendly Breakdown > Not medical advice, not personal advice. > ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.586
· Account tjphuhs@gmail.com
· 4/24/2026, 1:18:04 PM
MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from derekpruski@substack.com on 2026-04-24T17:18:04.000Z View this post on the web at https://derekpruski.substack.com/p/mots-c-vs-nad-the-beginners-guide I get a lot of questions about MOTS-c versus NAD+, and one of the most common is which one research protocols should implement first. This post breaks down what each one actually does, how they differ, and gives you a simple decision tree to think throu
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.585
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z mode. > • > Improves insulin sensitivity in preclinical models, meaning muscle cells pull glucose out of circulation more efficiently. > • > Appears to protect against metabolic stress in rodent studies (high-fat diet models). > • > Levels naturally decline with age, which some researchers think contributes to age-related metabolic dysfunction. > > >
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.585
· Account tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z mode. > • > Improves insulin sensitivity in preclinical models, meaning muscle cells pull glucose out of circulation more efficiently. > • > Appears to protect against metabolic stress in rodent studies (high-fat diet models). > • > Levels naturally decline with age, which some researchers think contributes to age-related metabolic dysfunction. > > >
MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.585
· Account tjphuhs@gmail.com
· 4/24/2026, 1:18:04 PM
MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from derekpruski@substack.com on 2026-04-24T17:18:04.000Z research is more nuanced and mostly preclinical. Can they be studied together? Mechanistically they don’t conflict, and there’s some theoretical rationale for why they might be complementary (signal plus substrate). But from a research design standpoint, studying both at once means you can’t tell which compound is driving any observed effect. One va
Does SS-31 Still Make Sense If MOTS-C Improves Mitochondria?
Score 0.585
· Account tjphuhs@gmail.com
· 4/5/2026, 1:05:35 PM
Does SS-31 Still Make Sense If MOTS-C Improves Mitochondria? from derekpruski@substack.com on 2026-04-05T17:05:35.000Z a well-defined signaling mechanism makes it clearer that SS-31 is filling a different role entirely — structural stabilization at the membrane level that MOTS-c doesn’t address. They’re not competing compounds. They’re targeting different layers of the same problem, which is exactly why they’re frequently discussed together in mitochondrial health research. As always — for resea
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds
Score 0.583
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 1:28:54 PM
Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds from tjphuhs@gmail.com on 2026-04-24T17:28:54.000Z on framing: Everything here is strictly for research use only. These compounds are not for human consumption. Nothing below is medical advice. This is educational content to help you understand what the research literature says about these molecules and how they function at the cellular level. > Upgrade to paid > The 30-Second Version > MOTS-c is a sm